71 studies found for:    EUCLID
Show Display Options
Rank Status Study
1 Active, not recruiting A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
Condition: Peripheral Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
2 Completed Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).
Conditions: Epstein-Barr Virus Infections;   Lymphoproliferative Disorders
Intervention: Biological: Intravenous injection of EBV specific CTLs
3 Terminated Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Intervention: Device: Dermal - Living Skin Replacement (Dermal - LSR)
4 Withdrawn Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone
Condition: Pain
Interventions: Drug: Ropivacaine;   Drug: Dexamethasone;   Drug: placebo
5 Completed Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
Conditions: Brain Tumor;   Brain Tumor, Recurrent;   Brain Neoplasm;   Brain Cancer;   Glioblastoma Multiforme;   Recurrent Glioblastoma Multiforme
Intervention: Device: AutoLITT system
6 Terminated
Has Results
Effects of Coenzyme Q10 (CoQ) in Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Coenzyme Q10 with vitamin E;   Drug: placebo with vitamin E
7 Terminated
Has Results
Interventional Management of Stroke (IMS) III Trial
Condition: Stroke
Interventions: Drug: IV rt-PA alone;   Other: endovascular therapy
8 Completed
Has Results
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris
Conditions: Tinea Cruris;   Jock Itch
Interventions: Drug: NAFT-500;   Drug: Placebo
9 Completed Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
10 Completed
Has Results
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis
Conditions: Tinea Pedis;   Athlete's Foot
Interventions: Drug: NAFT-500;   Drug: Placebo 2-weeks;   Drug: Naftin 1%;   Drug: Placebo 4-weeks
11 Completed
Has Results
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
Condition: Hypertension
Interventions: Drug: Olmesartan medoxomil;   Drug: Amlodipine;   Drug: Hydrochlorothiazide
12 Active, not recruiting Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: tamoxifen citrate;   Radiation: Radiation Therapy
13 Completed Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: etoposide;   Procedure: adjuvant therapy;   Radiation: radiation therapy
14 Completed Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Radiation: Prophylactic Cranial Irradiation (PCI)
15 Completed S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
Condition: Pancreatic Cancer
Interventions: Biological: cetuximab;   Drug: gemcitabine hydrochloride
16 Completed Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C;   Radiation: radiation therapy
17 Active, not recruiting
Has Results
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Conditions: Cervical Cancer;   Endometrial Cancer
Interventions: Drug: cisplatin;   Radiation: intensity-modulated radiation therapy
18 Completed
Has Results
A Study to Describe Pediatric Influenza Vaccine Coverage
Condition: Healthy
Intervention: Biological: Influenza vaccination
19 Terminated BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Trastuzumab;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: 5-Fluorouracil;   Drug: Epirubicin;   Drug: Cyclophosphamide
20 Completed Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: CD2475/101 40 mg Tablets;   Drug: Doxycycline 100 mg Capsules;   Drug: Placebo Tablet, and Placebo Capsule

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years